Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma

2020 JAMA 2,404 citations

Abstract

In this preliminary uncontrolled case series of 5 critically ill patients with COVID-19 and ARDS, administration of convalescent plasma containing neutralizing antibody was followed by improvement in their clinical status. The limited sample size and study design preclude a definitive statement about the potential effectiveness of this treatment, and these observations require evaluation in clinical trials.

Keywords

MedicineARDSConvalescent plasmaConvalescenceTiterPneumoniaMechanical ventilationCoronavirus disease 2019 (COVID-19)Internal medicineIntensive care medicineImmunologyEmergency medicineDiseaseAntibodyInfectious disease (medical specialty)Lung

Affiliated Institutions

Related Publications

Publication Info

Year
2020
Type
article
Volume
323
Issue
16
Pages
1582-1582
Citations
2404
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

2404
OpenAlex

Cite This

Chenguang Shen, Zhaoqin Wang, Fang Zhao et al. (2020). Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma. JAMA , 323 (16) , 1582-1582. https://doi.org/10.1001/jama.2020.4783

Identifiers

DOI
10.1001/jama.2020.4783